These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8134502)

  • 41. Tricyclic antidepressants in the treatment of depression. Do they still have a place?
    Judd F; Boyce P
    Aust Fam Physician; 1999 Aug; 28(8):809-13. PubMed ID: 10495531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of desipramine toxicity with citalopram.
    Ashton AK
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract]   [Full Text] [Related]  

  • 43. [Low dosages of tricyclic antidepressants].
    van Hemert AM; Birkenhäger TK
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):677-9. PubMed ID: 15819130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].
    Ostapowicz A; Zejmo M; Wrześniewska J; Białecka M; Górnik W; Gawrońska-Szklarz B
    Psychiatr Pol; 2000; 34(4):595-605. PubMed ID: 11059259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of antidepressants between plasma and red blood cells.
    Fisar Z; Fuksová K; Sikora J; Kalisová L; Velenovská M; Novotná M
    Neuro Endocrinol Lett; 2006 Jun; 27(3):307-13. PubMed ID: 16816836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays.
    Caravati EM; Juenke JM; Crouch BI; Anderson KT
    Ann Pharmacother; 2005 Sep; 39(9):1446-9. PubMed ID: 16046487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy.
    Berger A; Dukes E; Edelsberg J; Stacey B; Oster G
    Clin J Pain; 2007; 23(3):251-8. PubMed ID: 17314585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Plasma levels of metapramine and its 3 major metabolites in patients with depression. Results and preliminary interpretations].
    Bougerol T; Gouezo F; Pok Phak Rop P; Valli M; Durand A; Conquy T; Scotto JC; Viala A
    Encephale; 1990; 16(1):35-40. PubMed ID: 2328683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modern tricyclic antidepressant drugs are hardly distinguishable in efficacy or safety for treatment of depressive mood disorders in controlled clinical trials.
    Glassman AH; Davis JM
    J Clin Psychopharmacol; 1993 Aug; 13(4):296-9. PubMed ID: 8376622
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the role of plasma level monitoring of tricyclic antidepressants in clinical practice.
    Asberg M; Sjöqvist F
    Commun Psychopharmacol; 1978; 2(5):381-91. PubMed ID: 738018
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.
    Bagheri H; Picault P; Schmitt L; Houin G; Berlan M; Montastruc JL
    Br J Clin Pharmacol; 1994 Jan; 37(1):93-6. PubMed ID: 8148228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring tricyclic antidepressants.
    Sjöqvist F; Bertilsson L; Asberg M
    Ther Drug Monit; 1980; 2(1):85-93. PubMed ID: 6762705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment with tricyclic antidepressives. Before- and after tricyclic antidepressives].
    Laux G
    Pharm Unserer Zeit; 2008; 37(3):214-8. PubMed ID: 18446903
    [No Abstract]   [Full Text] [Related]  

  • 55. Charcoal enhancement of treatment for tricyclic-induced mania.
    Jain V; Swartz CM
    Pharmacopsychiatry; 2002 Sep; 35(5):197-9. PubMed ID: 12237792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tricyclic antidepressants and congestive cardiomyopathy].
    Braun M; Strasser RH
    Internist (Berl); 1997 Dec; 38(12):1236-8. PubMed ID: 9465331
    [No Abstract]   [Full Text] [Related]  

  • 58. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
    Adlersberg S; Toren P; Mester R; Rehavi M; Skolnick P; Weizman A
    Clin Neuropharmacol; 1994 Jun; 17(3):294-7. PubMed ID: 9316675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical implications of the pharmacokinetics of tricyclic antidepressants.
    Nelson JC; Mazure C; Jatlow PI
    Psychopharmacol Ser; 1989; 7():219-27. PubMed ID: 2687860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.